Page last updated: 2024-10-31

nafamostat and Orthomyxoviridae Infections

nafamostat has been researched along with Orthomyxoviridae Infections in 2 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Orthomyxoviridae Infections: Virus diseases caused by the ORTHOMYXOVIRIDAE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sato, K1
Hayashi, H1
Shimotai, Y1
Yamaya, M1
Hongo, S1
Kawakami, K1
Matsuzaki, Y1
Nishimura, H1
Asaka, M1
Ishikawa, I1
Nakazawa, T1
Tomosugi, N1
Yuri, T1
Suzuki, K1

Reviews

1 review available for nafamostat and Orthomyxoviridae Infections

ArticleYear
Hemolytic uremic syndrome associated with influenza A virus infection in an adult renal allograft recipient: case report and review of the literature.
    Nephron, 2000, Volume: 84, Issue:3

    Topics: Adult; Benzamidines; Cyclosporine; Guanidines; Hemolytic-Uremic Syndrome; Humans; Influenza A virus;

2000

Other Studies

1 other study available for nafamostat and Orthomyxoviridae Infections

ArticleYear
TMPRSS2 Activates Hemagglutinin-Esterase Glycoprotein of Influenza C Virus.
    Journal of virology, 2021, 10-13, Volume: 95, Issue:21

    Topics: Amino Acid Sequence; Animals; Antiviral Agents; Benzamidines; Cell Line; Cell Line, Tumor; Cells, Cu

2021